Growth hormone-releasing peptide-2 infusion synchronizes growth hormone, thyrotrophin and prolactin release in prolonged critical illness

European Journal of Endocrinology

Volumn 140, Issue 1, 1999, Pages 17-22

  Van Den Berghe, Greet ^c   Wouters, Pieter ^d   Bowers, Cyril Y ^a   De Zegher, Francis ^d   Bouillon, Roger ^d   Veldhuis, Johannes D ^b  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

^c UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; GROWTH HORMONE RELEASING FACTOR; PRALMORELIN; PROLACTIN; PROTIRELIN; THYROTROPIN;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CRITICAL ILLNESS; FEMALE; GROWTH HORMONE RELEASE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROLACTIN RELEASE; RANDOMIZED CONTROLLED TRIAL; THYROTROPIN RELEASE; ERRATUM; ERROR;

ADULT; AGED; AGED, 80 AND OVER; CRITICAL CARE; DRUG COMBINATIONS; GROWTH HORMONE; GROWTH HORMONE-RELEASING HORMONE; HORMONES; HUMANS; INFUSIONS, INTRAVENOUS; MIDDLE AGED; OLIGOPEPTIDES; PROLACTIN; THYROTROPIN;

EID: 0033051329     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.0.1400017     Document Type: Article

References (22)

1. Veldhuis JD, Iranmanesh A, Johnson MI, & Lizarralde G. Twenty-four-hour rhythms in plasma concentrations of adenohypophyseal hormones are generated by distinct amplitude and/or frequency modulation of underlying pituitary secretory bursts. Journal of Clinical Endocrinology and Metabolism 1990 71 1616-1625.
2. Sarapura VD, Samuels MH & Ridgway CE. Thyroid stimulating hormone. In The Pituitary. ch 1. pp 187-229. Ed S Melmed. Cambridge Massachusetts: Blackwell Science, 1995.
3. Samuels MH, Veldhuis J & Ridgway EC Copulsatile release of thyrotropin and prolactin in normal and hypothyroid subjects. Thyroid 1995 5 369-372.
4. Dunger DB, Matthews DR, Edge JA, Jones J & Preece MA. Evidence for temporal coupling of growth hormone, prolactin, LH and FSH pulsatility overnight during normal puberty. Journal of Endocrinology 1991 130 141-149.
5. Albers N, Bettendorf M, Herrmann H, Kaplan SL & Grumbach MM. Hormone ontogeny in the ovine fetus. XXVII. Pulsatile and copulsatile secretion of luteinizing hormone, follicle-stimulating hormone, growth hormone and prolactin in late gestation: a new method for the analysis of copulsatility. Endocrinology 1993 1 32 701-709.
6. de Zegher F, Devlieger H & Veldhuis JD. Properties of growth hormone and prolactin hypersecretion by the human newborn on the day of birth. Journal of Clinical Endocrinology and Metabolism 1993 76 1177-1181.
7. Frohman LA & Jansson JO. Growth hormone-releasing hormone. Edocrine Reviews 1986 7 223-253.
8. Jackson IMD. Thyrotropin releasing hormone. New England Journal of Medicine 1982 306 145-155.
9. Bowers CY, Momany FA, Reynolds GA & Hong A. On the in vitro and in vivo activity of a new synthetic hexapeptide that acts on the pituitary to specifically release growth hormone, Endocrinology 1984 114 1537-1545.
10. Howard AD, Feighner SD, Cully DF, Arena JP, Liberator PA. Rosenblum CI et al. A receptor in pituitary and hypothalamus that functions in growth hormone release. Science 1996 273 974-977.
11. Van den Berghe G, de Zegher F, Veldhuis JD, Wouters P. Awouters M. Verbruggen W et al. The somatotropic axis in critical illness: effect of continuous GHRH and GHRP-2 infusion. Journal of Clinical Endocrinology and Metabolism 1997 82 590-599.
12. Van den Berghe G, de Zegher F, Veldhuis JD, Wouters P, Gouwy S, Stockman W et al. Thyrotropin and prolactin release in prolonged critical illness: dynamics of spontaneous secretion and effects of growth hormone secretagogues. Clinical Endocrinology 1997 47 599-612.
13. Van den Berghe G, de Zegher F, Baxter RC, Veldhuis JD, Wouters P, Schetz M et al. Neuroendocrinology of critical illness: effect of continuous thyrotropin-releasing hormone infusion and its combination with growth hormone secretagogues. Journal of Clinical Endocrinology and Metabolism 1998 83 309-319.
14. Van den Berghe G, de Zegher F, Bowers CY, Wouters P, Muller P, Soetens F et al. Pituitary responsiveness to growth hormone (GH) releasing hormone. GH-releasing peptide-2 and thyrotropin releasing hormone in critical illness. Clinical Endocrinology 1996 45 341-351.
15. Knaus WA, Draper EA, Wagner DP & Zimmerman JE. APACHE II: a severity of disease classification system. Critical Care Medicine 1985 13 818-829.
16. Souba WW. Nutritional support. New England Journal of Medicine 1997 336 41-48.
17. Mizock BA. Alterations in carbohydrate metabolism during stress: a review of the literature. American Journal of Medicine 1195 98 75-84.
18. Bouillon R & De Moor P. Heterogeneity of human growth hormone in serum. Annales d'Endocrinologie 1974 35 606-613.
19. Mulligan T, Iranmanesh A, Johnson ML, Straume M & Veldhuis JD 1997 Aging alters feedforward and feedback linkages between LH and testosterone in healthy men. American Journal of Physiology 273 R1407-R1413.
20. Veldhuis JD, Johnson ML, Faunt LM & Souta E 1994. Assessing temporal coupling between two. or among three or more, neuroendocrine pulse trains: cross-correlation analysis, simulation methods, and conditional probability testing. Methods in Neurosciences 20 279-325.
21. Veldhuis JD, Johnson ML & Seneta E 1991. Analysis of the copulsatllity of anterior pituitary hormones. Journal of Clinical Endocrinology and Metabolism 73 569-576.
22. Horvath E & Kovacs K. Fine structural cytology of the adenohypophysis in rat and man. Journal of Electron Microscopy Techniques 1988 8 401-432.